You are here

  • Home
  • Archive
  • Volume 2, Issue 1
  • Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment

Article info

Article menu
Animal models
Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment

Authors

  • Biji T Kurien Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA Department Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Valerie M Harris Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Syed M S Quadri Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Patricia Coutinho-de Souza Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Joshua Cavett Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Amanda Moyer Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Bilal Ittiq Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Angela Metcalf Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Husayn F Ramji Oklahoma School of Science and Mathematics, Oklahoma City, Oklahoma, USA University of Oklahoma, Norman, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Dat Truong Oklahoma School of Science and Mathematics, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Ramesh Kumar Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Kristi A Koelsch Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA Department Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Mike Centola Haus Bioceuticals, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Adam Payne Haus Bioceuticals, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  • Debashish Danda Christian Medical College, Vellore, Tamil Nadu, India PubMed articlesGoogle scholar articles
  • R Hal Scofield Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA Oklahoma Medical Research Foundation, Arthritis & Clinical Immunology Program, Oklahoma City, Oklahoma, USA Department Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr R Hal Scofield; hal-scofield{at}omrf.ouhsc.edu
View Full Text

Citation

Kurien BT, Harris VM, Quadri SMS, et al
Significantly reduced lymphadenopathy, salivary gland infiltrates and proteinuria in MRL-lpr/lpr mice treated with ultrasoluble curcumin/turmeric: increased survival with curcumin treatment
Lupus Science & Medicine 2015;2:e000114. doi: 10.1136/lupus-2015-000114

Publication history

  • Received July 9, 2015
  • Revision received August 5, 2015
  • Accepted August 20, 2015
  • First published September 8, 2015.
Online issue publication 
May 01, 2020

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

    Files in this Data Supplement:

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/